search Created with Sketch.

Peer Review

Peer Review

Home-Based Glaucoma Monitoring

Tools for expanding glaucoma diagnosis and management beyond the office.

Kateki Vinod, MD, and Sarwat Salim, MD, FACS

Peer Review

IOL Selection for Glaucoma Patients

A review of the pros and cons of premium IOLs in glaucomatous eyes.

Susan Liang, MD, and Sarwat Salim, MD, FACS | Section Editor

Peer Review

Glaucoma Management in Nanophthalmos

Small eyes can present big challenges.

Mohammad Pakravan, MD

Peer Review

Management of Angle-Closure Glaucoma

Appropriate and timely intervention is crucial.

Chandrasekharan Krishnan, MD

Peer Review

Elevated IOP After Laser Treatment

Laser procedures that are ordinarily safe can sometimes have unexpected outcomes.

Frank Cao, MD, and Inci Irak Dersu, MD

Peer Review

Marijuana and Glaucoma

Side effects, health risks, and a short duration of action limit the usefulness of this drug.

Thomas A. Graul, MD

Peer Review

You Say You Want a Revolution

Antivascular endothelial growth factor agents have dramatically changed the early management of neovascular glaucoma.

Mark Slabaugh, MD, and Matthew Ohr, MD

Peer Review

Surgical Management of Traumatic Glaucoma

A stepwise approach.

Omolola O. Idowu, MBChB, MRCS(Ed), and Carla I. Bourne, MD

Peer Review

The Role of Perfusion Pressure

Risk factors other than IOP play a role in the pathogenesis of glaucoma.

Robert N. Weinreb, MD; Jeffrey M. Liebmann, MD; and Louis R. Pasquale, MD

Peer Review

Glaucoma in the Octogenarian

Considerations in treating the advanced elderly.

Samuel P. Solish, MD

Peer Review

Detecting and Treating Glaucoma in a Myopic Patient Without High IOP

Robert Chang, MD, and Kuldev Singh, MD, MPH

Peer Review

Cataract Surgery in High-Risk Glaucoma Patients

Do the risks outweigh the benefits?

Aaron M. Marble, BS; Bradley P. Roth, MS; and Barbara A. Smit, MD, PhD

Peer Review

The Role of 24-Hour IOP Monitoring in Glaucoma

Continuous monitoring would allow clinicians to develop a more complete IOP profile on which to base long-term treatment goals for patients.

Leonard K. Seibold, MD; Kaweh Mansouri, MD, MPH; Jeffrey R. SooHoo, MD; and Malik Y. Kahook, MD

Peer Review

Landmark Tube Trials

A review of key findings from recent multicenter randomized clinical trials involving tube shunts.

Ambika Hoguet, MD, and Steven J. Gedde, MD

Peer Review

Anterior Segment Imaging in Angle Closure

This technology has become a valuable tool for diagnosing, treating, and conducting research on angle closure.

Robert M. Feldman, MD

Peer Review

Cataract Surgery and IOP

An overview of current theories about why and how cataract extraction lowers IOP in some glaucoma patients.

Mark Slabaugh, MD, and Philip Chen, MD

Peer Review

Update on Microinvasive Glaucoma Surgery

A review of the pertinent data on three less invasive glaucoma procedures.

MICHAEL STILES, MD

Peer Review

The Role of SPARC in Trabecular Meshwork Extracellular Matrix Turnover and IOP Regulation

Developing an understanding of this matricellular protein may reveal molecular targets for the therapeutic treatment of primary open-angle glaucoma.

Ayan Chatterjee, MS; Dong-Jin Oh, PhD; Min Hyung Kang, PhD; Guadalupe Villarreal, MD; Ramez Haddadin, MD; Marc Töteberg-Harms, MD; Swarup S. Swaminathan, MD; and Douglas J. Rhee, MD

Peer Review

Anti-VEGF Therapy and Neovascular Glaucoma

Intravitreal injections improve visual outcomes, but the careful monitoring of patients after treatment is necessary.

Paul Harasymowycz, MD, MSc

Peer Review

What's New on the Tube?

Recent trends, updates, and controversy in aqueous shunt surgery.

HERBERT P. FECHTER, MD, PE

View more

Advertisement